Literature DB >> 21200322

Deletion of peroxiredoxin 6 potentiates lipopolysaccharide-induced acute lung injury in mice.

Dong Yang1, Yuanlin Song, Xun Wang, Jiayuan Sun, Yong Ben, Xiaojing An, Lin Tong, Jing Bi, Xiangdong Wang, Chunxue Bai.   

Abstract

OBJECTIVE: To investigate the role and signaling pathway of peroxiredoxin 6, a newly identified peroxidase, in lipopolysaccharide-induced acute lung injury.
DESIGN: Prospective, randomized, controlled study.
SETTING: Research laboratory.
SUBJECTS: Peroxiredoxin 6 (-/-) and wild-type C57BL/6 mice.
INTERVENTIONS: Wild-type or peroxiredoxin 6 (-/-) mice were challenged by intratracheal instillation of lipopolysaccharide (5 mg/kg) for 4 hrs or 24 hrs for lung injury measurement. In other studies, peritoneal macrophages, isolated from wild-type and peroxiredoxin 6 (-/-) mice, were preincubated in presence or absence of mitogen-activated protein kinases inhibitors for 30 mins before being stimulated with lipopolysaccharide (1 μg/mL) for 4 hrs.
MEASUREMENTS AND MAIN RESULTS: Bronchoalveolar lavage myeloperoxidase activity and the lung injury score were significantly increased in peroxiredoxin 6 (-/-) mice compared with wild-type mice after lipopolysaccharide instillation at both 4 hrs and 24 hrs. Hydrogen peroxide and malondialdehyde levels, as well as nuclear factor-κB activities, tumor necrosis factor-α, interleukin-1β, and matrix metalloproteinase-9 messenger RNA, protein concentration, and activities were significantly increased whereas total antioxidative capability was markedly decreased in lungs of peroxiredoxin 6 (-/-) mice compared with wild-type mice. In vitro studies showed intracellular reactive oxygen species levels and release of tumor necrosis factor-α, interleukin-1, and matrix metalloproteinase-9 were significantly increased in macrophages from peroxiredoxin 6 (-/-) mice compared with that from wild-type mice after lipopolysaccharide stimulation. Cytokines release was partially suppressed by extracellular signal-regulated kinase and c-Jun N-terminal kinase inhibitors, but not by the p38 mitogen-activated protein kinase inhibitor.
CONCLUSIONS: Deletion of peroxiredoxin 6 exaggerates lipopolysaccharide-induced acute lung injury and inflammation with increased oxidative stress, inflammatory responses, and matrix degradation, all of which were partially dependent on nuclear factor-κB, extracellular signal-regulated kinase, and c-Jun N-terminal kinase pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21200322     DOI: 10.1097/CCM.0b013e318206befd

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

1.  Genetic inactivation of the phospholipase A2 activity of peroxiredoxin 6 in mice protects against LPS-induced acute lung injury.

Authors:  José Pablo Vázquez-Medina; Jian-Quin Tao; Priyal Patel; Renata Bannitz-Fernandes; Chandra Dodia; Elena M Sorokina; Sheldon I Feinstein; Shampa Chatterjee; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

2.  Peptide targeting and imaging of damaged lung tissue in influenza-infected mice.

Authors:  Na Li; Lu Yin; Damien Thévenin; Yoshiyuki Yamada; Gino Limmon; Jianzhu Chen; Vincent Tk Chow; Donald M Engelman; Bevin P Engelward
Journal:  Future Microbiol       Date:  2013-02       Impact factor: 3.165

3.  Traumatic brain injury induces macrophage subsets in the brain.

Authors:  Christine L Hsieh; Charles C Kim; Bryan E Ryba; Erene C Niemi; Jennifer K Bando; Richard M Locksley; Jialing Liu; Mary C Nakamura; William E Seaman
Journal:  Eur J Immunol       Date:  2013-06-05       Impact factor: 5.532

4.  Inactivation of Peroxiredoxin 6 by the Pla Protease of Yersinia pestis.

Authors:  Daniel L Zimbler; Justin L Eddy; Jay A Schroeder; Wyndham W Lathem
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

Review 5.  The Roles of Peroxiredoxin 6 in Brain Diseases.

Authors:  Jiangfeng Liao; Yusi Zhang; Xiaochun Chen; Jing Zhang
Journal:  Mol Neurobiol       Date:  2021-05-19       Impact factor: 5.590

6.  Peroxiredoxin-6 Negatively Regulates Bactericidal Activity and NF-κB Activity by Interrupting TRAF6-ECSIT Complex.

Authors:  Yoon Min; Sae M Wi; Dongwoo Shin; Eunyoung Chun; Ki-Young Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-24       Impact factor: 5.293

Review 7.  NSFC spurs significant basic research progress of respiratory medicine in China.

Authors:  Ruijuan Sun; Feng Xu; Chen Wang; Erdan Dong
Journal:  Clin Respir J       Date:  2015-08-12       Impact factor: 2.570

8.  The β3/5 Integrin-MMP9 Axis Regulates Pulmonary Inflammatory Response and Endothelial Leakage in Acute Lung Injury.

Authors:  Yao Tong; Chengrong Bao; Yi-Qiong Xu; Lei Tao; Yao Zhou; Lei Zhuang; Ying Meng; Hui Zhang; Jingjing Xue; Weijun Wang; Lele Zhang; Qingbo Pan; Zhenzhen Shao; Tianran Hu; Qian Guo; Qingsheng Xue; Han Lu; Yan Luo
Journal:  J Inflamm Res       Date:  2021-10-05

9.  Peroxiredoxin 6 mediates the protective function of curcumin pretreatment in acute lung injury induced by serum from patients undergoing one-lung ventilation in vitro.

Authors:  Hui-Ting Li; Fang Tan; Tian-Hua Zhang; Long-Hui Cao; Hong-Ying Tan; Wen-Qian Lin; Wei-An Zeng; Xin-Jin Chi
Journal:  BMC Pulm Med       Date:  2022-05-12       Impact factor: 3.320

10.  Peroxiredoxin 6 overexpression attenuates lipopolysaccharide-induced acute kidney injury.

Authors:  Dong Hun Lee; Ju Ho Park; Sang Bae Han; Do Young Yoon; Yu Yeon Jung; Jin Tae Hong
Journal:  Oncotarget       Date:  2017-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.